BridgeMD
New treatment option for Uveitis
Official title Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis
ClinicalTrials.gov ID: NCT05388838
What this study is testing
What is Blood sample?
Blood sample is an investigational medicine, being studied as a potential treatment for uveitis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Uveitis is an inflammation of the uvea, an ocular tunic comprising the iris, ciliary body and choroid. This inflammation can also involve other tissues such as the retina, the optic nerve and the aqueous humor.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- GENERAL CRITERIA
- Male or female over 18 years of age,
- Free, informed, written consent signed by the patient and the investigator (at the latest on the day of inclusion) and before any examination...
- Patient affiliated to the social security system or beneficiary of such a system,
- Maximum volume of sampling (care + research) per 30-day period to be adapted according to the patient's weight (Order of April 12, 2018 establishing...
You likely can't join if
- -GENERAL CRITERIA
- Patient participating in an ongoing clinical trial at the time of the inclusion visit,
- Pregnant women, women in labor or nursing mothers,
- Persons deprived of liberty by a judicial or administrative decision,
- Persons under psychiatric care,
- Persons admitted to a health or social institution for purposes other than research,
See the full eligibility criteria
- GENERAL CRITERIA
- Male or female over 18 years of age,
- Free, informed, written consent signed by the patient and the investigator (at the latest on the day of inclusion) and before any examination required by the research,
- Patient affiliated to the social security system or beneficiary of such a system,
- Maximum volume of sampling (care + research) per 30-day period to be adapted according to the patient's weight (Order of April 12, 2018 establishing the list of research mentioned in 2° of Article L. 1121-1). SPECIFIC...
- -GENERAL CRITERIA
- Patient participating in an ongoing clinical trial at the time of the inclusion visit,
- Pregnant women, women in labor or nursing mothers,
- Persons deprived of liberty by a judicial or administrative decision,
- Persons under psychiatric care,
- Persons admitted to a health or social institution for purposes other than research,
- Persons of full age who are subject to a legal protection measure (guardianship, curatorship). SPECIFIC CRITERIA
- Patient for whom the diagnosis of ocular or cerebral lymphoma is uncertain,
- Patient with another systemic cancer that is evolving or in remission \< 2 years.
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.